Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Par Health, USA LLC

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Par Health, USA LLC with status Current. The shortage was first posted on Apr 10, 2020. Reported reason: Other

Shortage details

Status
Current
Company
Par Health, USA LLC
Package NDC
42023-146-25
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)
Initial Posting
Apr 10, 2020

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.